Form 425 Matinas BioPharma Holdin Filed by: Matinas BioPharma Holdings, Inc.

 

Filed by Matinas BioPharma Holdings, Inc.

pursuant to Rule 425 under the Securities Act of 1933

and deemed filed pursuant to Rule 14a-12

under the Securities Exchange Act of 1934

 

Subject Company: Matinas BioPharma Holdings, Inc.

Commission File No. 001-38022

 

Date: July 21, 2026

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Novo Nordisk A/S - share repurchase programme
• Formentera Partners and Daly Waters Energy Achieve First Natural Gas Sales from the Beetaloo Basin
• SunTec India Introduces AI-Accelerated Digital Engineering, Integrating AI Across the Software Development Lifecycle